DLC-1 gene deleted in cancers

Details DLC-1 gene deleted in cancers DLC-1 gene deleted in cancers

2005-05-24

2005-05-24

Ungar, Susan (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091100, C435S091200, C435S094000, C536S023100, C536S024300, C536S024310

Reexamination Certificate

active

06897018

ABSTRACT:
A cDNA molecule corresponding to a newly discovered human gene is disclosed. The new gene, which is frequently deleted in liver cancer cells and cell lines, is called the DLC-1 gene. Because the gene is frequently deleted in liver cancer cells, but present in normal cells, it is thought to act as a tumor suppressor. This gene is also frequently deleted in breast and colon cancers, and its expression is decreased or undetectable in many prostate and colon cancers. Also disclosed is the amino acid sequence of the protein encoded by the DLC-1 gene. Methods of using these biological materials in the diagnosis and treatment of hepatocellular cancer, breast cancer, colon cancer, prostate cancer, and adenocarcinomas are presented.

REFERENCES:
patent: 5330892 (1994-07-01), Vogelstein et al.
patent: 5571905 (1996-11-01), Vogelstein et al.
patent: 5576422 (1996-11-01), Vogelstein et al.
patent: 5624819 (1997-04-01), Skolnick et al.
patent: 5654155 (1997-08-01), Murphy et al.
patent: 5693473 (1997-12-01), Shattuck-Eidens et al.
patent: 5693536 (1997-12-01), Vogelstein et al.
patent: 5709999 (1998-01-01), Shattuck-Eidens et al.
patent: 5710001 (1998-01-01), Skolnick et al.
patent: 5912143 (1999-06-01), Bandman et al.
Lewin, B, ed, 1983, Genes, Wiley & Son, New York, p. 42, 346.*
Drexler et al (Leukemia and Lymphoma, 1993, 9:1-25.*
Embleton et al (Immunol Ser, 1984, 23:181-207).*
Hsu (in Tissue Culture Methods and Applications, Kruse and Patterson, Eds, 1973, Academic Press, NY, see abstract, p. 764).*
Jansen, M et al, 1995, Pediatric Res, 37 (6):681-686.*
Alberts et al. (Molecular Biology of the Cell, 3rd edition, 1994, p. 465).*
Shantz and Pegg (Int J of Biochem and Cell Biol., 1999, vol. 31, pp. 107-122).*
McClean and Hill (Eur J of Cancer, 1993, vol. 29A, pp. 2243-2248).*
Fu et al (EMBO Journal, 1996, vol. 15, pp. 4392-4401).*
Yokota, J et al (Oncogene, 1988, vol. 3, pp. 471-475).*
Zimmer (Cell Motility and the Cytoskeleton, 1991, vol. 20, pp. 325-337).*
Hell et al (Laboratory Investigation, 1995, vol. 73, pp. 492-496).*
Guo et al (Journal of Pharmacology and Experimental Therapeutics, 2002, vol. 300, pp. 206-212).*
Bergerheim et al.,Genes, Chromosomes&Cancer3:215-220 (1991).
Emi et al.,Genes, Chromosomes&Cancer7:152-157 (1993).
Cher et al.,Genes, Chromosomes&Cancer11:153-162 (1994).
Isola et al.,American J. of Pathology147(4):905-911 (1995).
Visakorpi et al.,Cancer Research55:342-347 (1995).
Chinen et al.,Cytogenet Cell Genes75:190-196 (1996).
Brothman,Cancer Genet Cytogenet95:116-121 (1997).
Marchio et al.,Genes, Chromosomes&Cancer18:59-65 (1997).
Friend et al.,New England J. of Medicine338(2):125-126 (1998).
Chinen et al., “Isolation of 45 exon-like fragments from 8p22→p21.3, a region that is commonly deleted in hepatocellular, colorectal, and non-small cell lung carcinomas,”Cytogenet Cell Genet, vol. 75, pp. 190-196 (1996).
Homma et al., “A dual functional signal mediator showing RhoGAP and Phospholipase C-δ stimulating activities,”The EMBO Journal, vol. 14, No. 22, pp. 286-291 (1995).
Symons, “Rho Family GTPases: the cytoskeleton and beyond,”TIBS, vol. 21, pp. 178-181 (1996).
Wei et al., “Cloning and Molecular Characterization of the Human Ortholog of the Rat Dual Regulator p122RhoGAP,”EMBL Database Entry AF026219(Abstract, 1977).
Yuan et al., Homo sapiens deleted in liver cancer-1 (DLC-1) mRNA, complete cds.,EMBL Database Entry AF035119(Abstract, 1997).
Yuan et al., “Cloning, Characterization, and Chromosomal Localization of a Gene Frequently Deleted in Human Liver Cancer (DLC-1) Homologous to RatRhoGAP,” Cancer Research, vol. 58, pp. 2196-2199 (1998).

Affiliated with

Also associated with

Rating

DLC-1 gene deleted in cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DLC-1 gene deleted in cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DLC-1 gene deleted in cancers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3447674